申请人:Janssen Pharmaceutica N.V.
公开号:US07655670B2
公开(公告)日:2010-02-02
The present invention is directed to novel 3-spirocyclic indolyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the ORL-1 receptor.
本发明涉及新型的3-螺环吲哚衍生物,包含它们的制药组合物以及它们在治疗被ORL-1受体调节的疾病和状况中的应用。